http://rdf.ncbi.nlm.nih.gov/pubchem/patent/ES-2340220-T3
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0d269c8e41f178194d858c230c9f85e3 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-06 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P13-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P11-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D205-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P1-04 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D205-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-397 |
| filingDate | 2007-09-04-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2010-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_800ec9a5a31cefec45cbf9e9f4476dab http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b677f69c12e78982e759681cd30a34db http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_9b9618be6dd88b13ef4f378ee90e9f7d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_639709ff598c8a1772becc94f93bf9b0 |
| publicationDate | 2010-05-31-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | ES-2340220-T3 |
| titleOfInvention | DERIVATIVES OF AZETIDINE AS ANTAGONIST AGENTS OF THE MUSCARINIC RECEIVER. |
| abstract | A compound of formula (I) ** (See formula) ** in which, - R1 is CN or CONH2; - R2 and R3 are methyl, or, R2 and R3 can also form together with the carbon atom to which a cyclopentane ring is attached; - X is NH or S; - p is 0 or 1; - A1 is selected from a) phenyl optionally substituted with 1, 2 or 3 groups independently selected from halo, CN, CF3, OR4, SR4, OCF3, (C1-C4) alkyl and phenyl optionally substituted with OH; b) naphthyl optionally substituted with 1 or 2 groups independently selected from halo, CN, CF3, OR4, SR4, OCF3 and (C1-C4) alkyl; c) a 9 or 10-membered bicyclic aromatic heterocyclic group, containing between 1 and 3 heteroatoms independently selected from O, S or N, said heterocyclic group that is optionally substituted with 1 or 2 substituents selected from OR4, (C1-C4 alkyl) ) and halo; - R4 is H or (C1-C4) alkyl; or its pharmaceutically acceptable salts or solvates. |
| priorityDate | 2006-09-22-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 319.